A water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia attenuates the small intestinal injury induced by anti-cancer drugs

Kashimoto,Naoki; Ishii,Satomi; Myojin,Yuki; Ushijima,Mitsuyasu; Hayama,Minoru; Watanabe,Hiromitsu

doi:10.3892/ol_00000011

A water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia attenuates the small intestinal injury induced by anti-cancer drugs

Authors:
- Naoki Kashimoto
- Satomi Ishii
- Yuki Myojin
- Mitsuyasu Ushijima
- Minoru Hayama
- Hiromitsu Watanabe
View Affiliations

Affiliations: Health Care Institute, Wakunaga Pharmaceutical Co. Ltd., Hiroshima 739-1195, Japan. kashimoto_n@wakunaga.co.jp
Published online on: January 1, 2010 https://doi.org/10.3892/ol_00000011
Pages: 63-68

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated whether a water-soluble extract from the culture medium of Ganoderma lucidum (Reishi) mycelia (MAK) is able to protect the small intestine against damage induced by anti-cancer drugs. Six-week-old male B6C3F1/Crlj mice were fed a basal diet (MF) alone or with various doses of MAK or Agarics blazei Murrill (AGA) beginning one week before treatment with the anti-cancer drugs. Mice were sacrificed 3.5 days after injection of the anti-cancer drug, the small intestine was removed and tissue specimens were examined for the regeneration of small intestinal crypts. In experiment 1, the number of regenerative crypts after the administration of 5-fluorouracil (5FU) intravenously (250 mg/kg) or intraperitoneally (250 or 500 mg/kg) was compared after treatment with MAK or AGA. MAK protected against 5FU-induced small intestinal injury whereas AGA did not. In experiment 2, we investigated the protective effect of MAK against small intestinal injury induced by the anti-cancer drugs: UFT (tegafur with uracil; 1,000 mg/kg, orally), cisplatin (CDDP; 12.5 and 25 mg/kg, intraperitoneally), cyclophosphamide (CPA; 250 mg/kg, orally) and gefitinib (Iressa; 2,000 and 4,000 mg/kg, orally). UFT and CDDP decreased the number of regenerative crypts, but treatment with MAK attenuated the extent of UFT- or CDDP-induced small intestinal injury. CPA or Iressa plus MAK up-regulated crypt regeneration. The present results indicate that MAK ameliorates the small intestinal injury caused by several anti-cancer drugs, suggesting that MAK is a potential preventive agent against this common adverse effect of chemotherapy.

View Figures

View References

1	Lin ZB: Pharmacological functions of Ganoderma lucidum. Modern Research of Ganoderma Lucidum. Lin ZB: 2nd edition. Beijing Medical University Press; pp. 284–309. 2001
2	Wasser SP and Weis AL: Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspective. Int J Med Mushrooms. 1:31–62. 1999. View Article : Google Scholar
3	Shiao MS: Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities and pharmacological functions. Chem Rec. 3:172–180. 2003. View Article : Google Scholar : PubMed/NCBI
4	Hu H, Ahn NS, Yang X, Lee YS and Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer. 102:250–253. 2002. View Article : Google Scholar
5	Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr and Ho NW: Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun. 298:603–612. 2002. View Article : Google Scholar
6	Ghafar MA, Golliday E, Bingham J, Mansukhani MM, Anastasiadis AG and Katz AE: Regression of prostate cancer following administration of genistein combined polysaccharide (GCP™), a nutritional supplement: a case report. J Altern Complement Med. 8:493–497. 2002.PubMed/NCBI
7	Gao Y, Zhou S, Jiang W, Huang M and Dai X: Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 32:201–215. 2003.PubMed/NCBI
8	Song YS, Kim SH, Sa JH, Jin C, Lim CJ and Park EH: Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol. 90:17–20. 2004. View Article : Google Scholar : PubMed/NCBI
9	Lakshmi B, Ajith TA, Sheena N, Gunapalan N and Janardhanan KK: Antiperoxidative, anti-inflammatory and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India. Teratog Carcinog Mutagen. 1:85–97. 2003. View Article : Google Scholar : PubMed/NCBI
10	Lu H, Uesaka T, Katoh O, Kyo E and Watanabe H: Prevention of the development of preneoplastic lesions, aberrant crypt foci, by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male F344 rats. Oncol Rep. 8:1341–1345. 2001.PubMed/NCBI
11	Lu H, Kyo E, Uesaka T, Katoh O and Watanabe H: Prevention of development of N,N′-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice. Int J Mol Med. 9:113–117. 2002.
12	Lu H, Kyo E, Uesaka T, Katoh O and Watanabe H: A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats. Oncol Rep. 10:375–379. 2003.PubMed/NCBI
13	Kashimoto N, Hayama M, Kamiya K and Watanabe H: Inhibitory effect of a water-soluble extract from the culture medium of Ganoderma lucidum (Rei-shi) mycelia on the development of pulmonary adenocarcinoma induced by N-nitrosobis (2-hydroxypropyl) amine in Wistar rats. Oncol Rep. 16:1181–1187. 2006.PubMed/NCBI
14	Kubo N, Myojin Y, Shimamoto F, Kashimoto N, Kyo E, Kamiya K and Watanabe H: Protective effects of a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia and Agaricus blazei Murrill against X-irradiation in B6C3F1 mice: increased small intestinal crypt survival and prolongation of average time to animal death. Int J Mol Med. 15:401–406. 2005.PubMed/NCBI
15	Wang CZ, Basila D, Aung HH, Mehendale SR, Chang WT, McEntee E, Guan X and Yuan CS: Effects of Ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model. Am J Chin Med. 33:807–815. 2005.
16	Zhuang SR, Chen SL, Tsai JH, Huang CC, Wu TC, Liu WS, Tseng HC, Lee HS, Huang MC, Shane GT, Yang CH, Shen YC, Yan YY and Wang CK: Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy. Phytother Res. 23:785–790. 2009. View Article : Google Scholar
17	Nonaka Y, Ishibashi H, Nakai M, Shibata H, Kiso Y and Abe S: Soothing effect of Ganoderma lucidum antlered form on cyclophosphamide-induced adverse reaction. Jpn J Cancer Chemother (in Japanese). 32:1586–1588. 2005.PubMed/NCBI
18	Nonaka Y, Ishibashi H, Nakai M, Shibata H, Kiso Y and Abe S: Effects of the antlered form of Ganoderma lucidum on tumor growth and metastasis in cyclophosphamide-treated mice. Biosci Biotechnol Biochem. 72:1399–1408. 2008.PubMed/NCBI
19	Kashimoto K, Ishii S, Nishihama T, Yanagida M, Hayama M and Watanabe H: Effects of a water-soluble extract of Ganoderma lucidum mycelia (MAK) on ACF and crypt survival by 5-FU in F344 rats. In: 67th Annual Meeting of the Japanese Cancer Association Proceedings; pp. 3832008
20	Tong MH, Chien PJ, Chang HH, Tsai MJ and Sheu F: High processing tolerances of immunomodulatory proteins in Enoki and Reishi mushrooms. J Agric Food Chem. 56:3160–3166. 2008. View Article : Google Scholar : PubMed/NCBI
21	Inomata S, Takahashi H, Nagata M, Yamada G, Shiratori M, Tanaka H, Satoh M, Saitoh T, Sato T and Abe S: Acute lung injury as an adverse event of gefitinib. Anticancer Drugs. 15:461–467. 2004. View Article : Google Scholar : PubMed/NCBI
22	Fukatsu K, Nagayoshi H, Maeshima Y, Ueno C, Saitoh D and Mochizuki H: Fish oil infusion reverses 5-fluorouracil-induced impairments in mucosal immunity in mice. Clin Nutr. 27:269–275. 2008. View Article : Google Scholar : PubMed/NCBI
23	Strober W, Fuss IJ and Blumberg RS: The immunology of mucosal models of inflammation. Annu Rev Immunol. 20:495–549. 2002. View Article : Google Scholar : PubMed/NCBI
24	Kashimoto N, Kyo E, Uesaka T, Katoh O and Watanabe H: Immunomodulation and antitumor activities of a water soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia. J Jpn Mibyo Sys Assoc (in Japanese). 9:293–296. 2003.
25	Ohmori K, Ito M, Kishi M, Mizutani H, Katada T and Konishi H: Effect of Reishi mushroom on side effects induced by CDDP. Biotherapy (in Japanese). 9:95–98. 1995.